The event is a yearly invitation-only networking forum for industry CEOs and decision makers in the life sciences, in particular from the Massachusetts and greater Boston Biotech hub. Attendees are invited to interact and gain insights from presentations and panels featuring CEOs from several of the world’s leading biopharmaceutical companies that are at the forefront of scientific innovation and drug development. Several venture capital and private equity leaders also participated and shared the latest trends in M&A and R&D collaborations across the sector. Several nominees participated in the Lifetime Achievement Award in Biotech and life sciences. The award was presented to MassBio’s President & CEO Robert K. Coughlin.
Each year’s award winner is chosen in an anonymous vote by conference attendees and recognizes the recipient’s commitment to advancing the life sciences industry. “Bob is a tireless champion for Massachusetts companies, the life sciences industry and, most importantly, the patients in need of innovative treatments and cures. The role he has played in building MassBio and supporting the industry has been critical to achieving Massachusetts’ world-leading status as a life sciences cluster,” said Christoph Westphal, CEO, Flex Pharma and Partner, Longwood Fund.